阿利罗库单抗
血管内超声
急性冠脉综合征
医学
心脏病学
动脉粥样硬化
内科学
PCSK9
冠状动脉粥样硬化
冠状动脉疾病
胆固醇
心肌梗塞
脂蛋白
低密度脂蛋白受体
载脂蛋白A1
作者
Junya Ako,Kiyoshi Hibi,Kenichi Tsujita,Takafumi Hiro,Yoshihiro Morino,Ken Kozuma,Toshiro Shinke,Hiromasa Otake,Kiyoko Uno,Michael J. Louie,Yoshiharu Takagi,Katsumi Miyauchi
出处
期刊:Circulation journal
[The Japanese Circulation Society]
日期:2019-09-25
卷期号:83 (10): 2025-2033
被引量:32
标识
DOI:10.1253/circj.cj-19-0412
摘要
Background:In patients with acute coronary syndrome (ACS), alirocumab reduced the risk of recurring ischemic events. ODYSSEY J-IVUS assessed the effect of alirocumab on coronary atheroma volume in Japanese patients recently hospitalized with ACS and hypercholesterolemia, using intravascular ultrasound imaging analysis.
科研通智能强力驱动
Strongly Powered by AbleSci AI